Search details
1.
Whole-genome landscapes of major melanoma subtypes.
Nature
; 545(7653): 175-180, 2017 05 11.
Article
in English
| MEDLINE | ID: mdl-28467829
2.
Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to Immunotherapy.
Trends Immunol
; 40(4): 328-344, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30853334
3.
Sex bias of females in survival from cancer and infections. Is X the answer?
Br J Cancer
; 124(7): 1184-1186, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33469152
4.
Co-targeting bromodomain and extra-terminal proteins and MCL1 induces synergistic cell death in melanoma.
Int J Cancer
; 147(8): 2176-2189, 2020 10 15.
Article
in English
| MEDLINE | ID: mdl-32249419
5.
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.
N Engl J Med
; 376(23): 2211-2222, 2017 06 08.
Article
in English
| MEDLINE | ID: mdl-28591523
6.
MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol
; 19(7): 916-929, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29908991
7.
HDAC inhibitors restore BRAF-inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma.
Int J Cancer
; 142(9): 1926-1937, 2018 05 01.
Article
in English
| MEDLINE | ID: mdl-29210065
8.
Anti-PD-1-induced high-grade hepatitis associated with corticosteroid-resistant T cells: a case report.
Cancer Immunol Immunother
; 67(4): 563-573, 2018 Apr.
Article
in English
| MEDLINE | ID: mdl-29289977
9.
Developing an e-learning resource for nurse airway assistants in the emergency department.
Br J Nurs
; 26(4): 217-221, 2017 Feb 23.
Article
in English
| MEDLINE | ID: mdl-28230439
10.
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.
N Engl J Med
; 369(2): 134-44, 2013 Jul 11.
Article
in English
| MEDLINE | ID: mdl-23724846
11.
Dynamics of chemokine, cytokine, and growth factor serum levels in BRAF-mutant melanoma patients during BRAF inhibitor treatment.
J Immunol
; 192(5): 2505-13, 2014 Mar 01.
Article
in English
| MEDLINE | ID: mdl-24489105
12.
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.
JAMA
; 315(15): 1600-9, 2016 Apr 19.
Article
in English
| MEDLINE | ID: mdl-27092830
13.
Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib.
N Engl J Med
; 366(8): 707-14, 2012 Feb 23.
Article
in English
| MEDLINE | ID: mdl-22356324
14.
Improved survival with MEK inhibition in BRAF-mutated melanoma.
N Engl J Med
; 367(2): 107-14, 2012 Jul 12.
Article
in English
| MEDLINE | ID: mdl-22663011
15.
Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases.
Mod Pathol
; 28(12): 1535-44, 2015 Dec.
Article
in English
| MEDLINE | ID: mdl-26403784
16.
Expression of the class 1 histone deacetylases HDAC8 and 3 are associated with improved survival of patients with metastatic melanoma.
Mod Pathol
; 28(7): 884-94, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-25836739
17.
Side effects and toxicities of targeted therapies in stage IV melanoma.
Am J Ther
; 22(1): 44-53, 2015.
Article
in English
| MEDLINE | ID: mdl-24185314
18.
Melanoma early detection and awareness: how countries developing melanoma awareness programs could benefit from melanoma-proficient countries.
Am J Ther
; 22(1): 37-43, 2015.
Article
in English
| MEDLINE | ID: mdl-24914500
19.
Pembrolizumab joins the anti-PD-1 armamentarium in the treatment of melanoma.
Future Oncol
; 11(1): 133-40, 2015.
Article
in English
| MEDLINE | ID: mdl-25572788
20.
Shedding light on dabrafenib-induced fevers in patients with melanoma.
Lancet Oncol
; 20(12): 1637-1638, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31797778